N@N

VAUDREUIL-DORION, QUEBEC--(Marketwire - May 13, 2010) - Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company"), today announced that it has completed the transaction to acquire certain assets and inventory used by Botanutric de Mexico SA de CV which was previously announced on May 3^rd, 2010.

With the closing of this transaction, the Company is now operating in 28 countries in its seamless worldwide network. "We are very pleased to welcome the distributors from our former licensee Botanutric de Mexico into the Immunotec family. This purchase forms the foundation for the continuation of significant growth in Mexico", stated James A. Northrop, Chief Executive Officer. The Company will be conducting a number of events over the next several months culminating in Grand Opening events in major cities across Mexico in September 2010.

About Immunotec Inc.

Immunotec is a Network Marketing Company involved in the direct selling of scientifically validated natural health products and dietary supplements. The Company offers a lucrative business opportunity to its independent distributors. This business model provides Immunotec's network of people with an opportunity to earn a steady and recurring income, directly based on their level of involvement and performance. Individual distributors build their business by conveying product information and selling product to customers and by building teams of distributors to expand geographic penetration and market coverage to larger populations of customers.

Headquartered with manufacturing facilities near Montreal, Canada, the Company also subcontracts certain distribution logistics and capacity to support its activities in the United States, Europe, Mexico and The Caribbean.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at [ www.sedar.com ] and on the Company's website at [ www.immunotec.com ]. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at [ www.sedar.com ]. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

The TSX Venture does not accept responsibility for the adequacy or accuracy of this release.